Synthesis of 1-β-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus

There are no FDA approved drugs for the treatment of hemorrhagic fever with renal syndrome (HFRS), a serious human illnesses caused by hantaviruses. Clinical studies using ribavirin (RBV) to treat HFRS patients suggest that it provides an improved prognosis when given early in the course of disease....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chung, Dong-Hoon, Kumarapperuma, Sidath C., Sun, Yanjie, Li, Qianjun, Chu, Yong-Kyu, Arterburn, Jeffrey B., Parker, William B., Smith, Jeffrey, Spik, Kristin, Ramanathan, Harish, Schmaljohn, Connie S., Jonsson, Colleen B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2008
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2692291/
https://ncbi.nlm.nih.gov/pubmed/18394724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2008.02.003
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi